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Abstract
Introduction: Sympathetic ophthalmia (SO) is a rare, bilateral, diffuse granulomatous uveitis that usually occurs
after open globe injury or intraocular surgery.
Methods: A patient developed SO following therapeutic penetrating keratoplasty (TPK) with cataract extraction in
the exciting eye following fungal keratitis. The sympathizing eye presented with only posterior segment findings
(exudative retinal detachment) and responded well with oral corticosteroids.
Results: Graft remained clear in the left eye and the right eye; the best-corrected visual acuity (BCVA) improved to
0.2 log MAR.
Conclusion: SO presenting after TPK for fungal keratitis is a rare occurrence but if detected early can be managed
effectively.
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Introduction
Sympathetic ophthalmia (SO) has been defined as a
“specific bilateral inflammation of the entire uveal tract
of unknown etiology, characterised clinically by an insidi-
ous onset and a progressive course with exacerbation, and
pathologically by a nodular or diffuse infiltration of the
uveal tract with lymphocytes and epithelioid cells” [1].
Case history
A 48-year-old female presented to us with decrease in
vision, redness and pain in the left eye (LE) 3 weeks after
an injury with a stick. An informed consent was taken,
and approval from the Nethradhama eye hospital review
board was obtained. On examination, her best-corrected
visual acuity (BCVA) was hand movement (HM+) in LE
and 0 log MAR in the right eye (RE). A diagnosis of fungal
ulcer in the LE was made after a thorough clinical examin-
ation and laboratory investigations which included potas-
sium hydroxide mount (KOH), Sabouraud’s dextrose agar
(SDA), and she was started on Natamet (natamycin 5 %
Sun Pharma, India) eye drops hourly, Itral 1 % ointment
(itraconazole, Java Pharma, India) three times a day, and
Atropine eye ointment (Atropine 1 %, Java Pharma, India).
The ulcer did not show any signs of improvement with
medical treatments after 7 days, and accelerated cross-
linking (KXL) was done in the LE with riboflavin 0.1 % so-
lution (Vibex Rapid-Riboflavin 0.1 % with hydroxypropyl
methylcellulose) applied every 2 min for 10 min before
the irradiation. The cornea was then exposed to ultraviolet
radiant energy from a solid-state UV lamp source (light-
emitting diode (LED)) at a wavelength of 365–370 nm (in
the UV-A spectral band) at an irradiance (“exposure dose
rate”) of 30 mW/cm2 for 3 min to achieve a total radiant
exposure (“total dose”) of 5.4 J/cm2. The ulcer still pro-
gressed, and a therapeutic penetrating keratoplasty (TPK)
was done with cataract extraction as the lens was catarac-
tous and postoperative antifungal therapy was continued.
Posterior capsule was intact, and no intraocular lens was
placed. Topical zymaxid eye drops (Gatifloxacin 0.5 %,
Allergan, CA, USA) and flur eye drops (Flurbiprofen
0.03 %, Allergan, CA, USA) was started. Graft remained
clear in the postoperative period (Fig. 1). Under the cover
of anti-fungals, topical steroids were started at the end of
4 weeks, Lotepred eye drops (Loteprednol 0.3 %, Sun
Pharma, India) was started with a frequency of four times
per day. She presented with decrease in vision and floaters
in the RE at the end of 3 months. On examination, BCVA
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in the RE was 0.4 log MAR and HM+ in the LE; on exam-
ination of the RE, the anterior chamber (AC) was optically
clear, lens was clear but an exudative retinal detachment
was seen on dilated fundus examination. Anterior seg-
ment optical coherence tomography (AS-OCT) and fun-
dus fluorescein angiography (FFA) were done to confirm
the diagnosis. FFA showed pinpoint leakage (Fig. 2), and
AS-OCT showed an exudative retinal detachment. The LE
did not show any AC reaction possibly due to use of top-
ical steroids and showed no posterior segment changes.
Patient was started on systemic corticosteroids at the dose
of 1.5 mg/kg body weight for 2 weeks and then tapered to
1 mg/kg body weight with weekly tapering to a period of
6 weeks. Patients gradually responded to the treatment
with resolution of exudative detachment and leakage on
FFA and BCVA of 0.2 log MAR in the RE. Patient was
started on systemic methotrexate 15 mg/kg body weight
once a week with folic acid supplement after consulting
an immunologist. BCVA is maintained in the RE, and
graft is clear in the left eye.
Discussion
Sympathetic ophthalmia occurs following penetrating
injury or surgical procedures in one eye threatening sight
in the fellow eye. Epidemiological estimates have shown
the incidence to be 0.2 to 0.5 % after penetrating ocular
injuries and 0.01 % after intraocular surgery [2,3].
The time from ocular injury to onset of SO varies
from a few days to decades, with 80 % of the cases oc-
curring within 3 months after injury to the exciting eye
and 90 % within 1 year [4]. The classical description of
signs include granulomatous mutton fat keratic precipi-
tates, anterior chamber, and vitreous inflammation with
or without yellow–white lesions in the retinal periphery.
Other fundus lesions like retinal detachment, papillitis,
optic atrophy, and vasculitis are reported uncommonly
and are generally seen in conjunction with anterior seg-
ment inflammation [5]. Mcpherson et al. have reported
two cases with atypical form of sympathetic ophthalmia
with only posterior segment findings and termed it as
“posterior sympathetic ophthalmia” [6]. The diagnosis of
sympathetic ophthalmia is based on history and clinical
examination. There are no specific laboratory studies to
establish the diagnosis of SO; however, focused clinical
testing can be used to rule out other disease entities with
a similar clinical picture. Fluorescein angiography (FA)
and indocyanine green video-angiography (ICG-V) are
useful adjuncts in establishing the extent and severity of
SO. Fluorescein angiography during acute sympathetic
Fig. 1 Clear graft following TPK
Fig. 2 Pinpoint leakage on FFA in RE
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ophthalmia shows an exudative process and may provide
evidence of multifocal areas of early hyperfluorescence
(pinpoints) and leakage in the retinal pigment epithelium
[1].Galor et al. found that although ocular complications
were seen in many sympathizing eyes with SO, most
patients maintained functional VA. The presence of an
exudative retinal detachment and active intraocular
inflammation correlated with poorer vision in the sym-
pathizing eye [7].
A similar case of sympathetic uveitis after a tectonic
corneal-scleral keratoplasty because of a fungal keratitis
is reported by Magalhaes et al. where they studied the
spectral-domain optical coherence tomographic changes
in the sympathizing eye [8]. To our best knowledge, this
is the first reported case of SO following TPK+cataract
extraction following fungal keratitis with atypical SO
manifesting only with posterior segment findings.
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